About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNCT07382128

Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes

This observational study aims to evaluate myocardial perfusion abnormalities using quantitative and qualitative cardiac magnetic resonance (CMR) perfusion imaging in patients with hypertrophic cardiom...

Lead sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Luigi Lovato

CONTACT

+390512144740 luigi.lovato@aosp.bo.it

Sponsors

Lead Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•A confirmed diagnosis of cardiomyopathy with a hypertrophic phenotype, according to current ESC guidelines; or a first-degree relative of a patient with a confirmed diagnosis of cardiomyopathy with a hypertrophic phenotype; or a carrier of a genetic mutation for hypertrophic cardiomyopathy (carriers).
•Patient with an indication to undergo cardiac magnetic resonance imaging (CMR) according to current ESC guidelines.
•Age ≥ 18 years
•Written informed consent obtained

Exclusion Criteria

•\- History of previous myocardial infarction or myocardial revascularization (coronary artery bypass grafting or percutaneous coronary angioplasty) and/or evidence of coronary stenosis ≥ 50% on coronary CT scan or invasive coronary angiography.

Related studies

Left Bundle Branch Pacing in Patients With Hypertrophic Cardiomyopathy After Myectomy

NCT07372196 · HCM - Hypertrophic Cardiomyopathy, Sudden Cardiac Death, and more

Multimodal Imaging Assessment After Revascularization in Patients With Acute Myocardial Infarction

NCT07130409 · Cardiac Magnetic Resonance Imaging, Acute Myocardial Infarction (AMI), and more

Active Not Recruiting

Stratification, Management, and Guidance of Hypertrophic Cardiomyopathy Patients Using Hybrid Digital Twin Solutions

NCT07131371 · HCM - Hypertrophic Cardiomyopathy

Evaluation of a Free-breathing Cardiac Cine-MRI Sequence With Image Reconstructions by Deep-Learning in Ischemic Heart Disease

NCT05105984 · Magnetic Resonance Imaging, Cardiac Magnetic Resonance Imaging, and more

Observational Study for Patients With Hypertrophic Cardiomyopathy

NCT04851652 · HCM - Hypertrophic Cardiomyopathy

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 2, 2026Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment250

Start dateJun 2025

Last updatedFeb 2, 2026

Condition

HCM - Hypertrophic Cardiomyopathy Anderson Fabry Disease Cardiac Magnetic Resonance Imaging Amyloid Cardiomyopathy

Locations shown

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, BO

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 2, 2026Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions